학술논문
Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes.
Document Type
Article
Author
Source
Subject
*RESEARCH
*CLINICAL trials
*CONFIDENCE intervals
*HYPOGLYCEMIC agents
*TYPE 2 diabetes
*INSULIN
*TREATMENT effectiveness
*COMPARATIVE studies
*T-test (Statistics)
*INSULIN pumps
*RESEARCH funding
*DESCRIPTIVE statistics
*QUESTIONNAIRES
*DATA analysis software
*PATIENT safety
*LONGITUDINAL method
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0891-8929
Abstract
The t:slim X2 insulin pump with Control-IQ technology (Control-IQ) advanced hybrid closed-loop automated insulin delivery system was evaluated in this prospective single-arm trial. Thirty adults with type 2 diabetes using the Control-IQ system showed substantial glycemic improvement with no increase in hypoglycemia. Mean time in range (70–180 mg/dL) improved 15%, representing an increase of 3.6 hours/day, and mean glucose decreased by 22 mg/dL. [ABSTRACT FROM AUTHOR]